Clinuvel Pharmaceuticals LimitedASX: CUV

CLINUVEL update on Level II ADR upgrade, Nasdaq uplist

· Issued by Clinuvel Pharmaceuticals Limited
Watch Clinuvel Pharmaceuticals explain itClinuvel Pharmaceuticals Limited (CUV) Q4 2026 Earnings Call · Replay · Aug 27

Clinuvel Pharmaceuticals Ltd has released a press release.

View Attachment

Company analysis

Earlier from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases